Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,520 | -51,102 | -24,295 | -60,508 | -28,447 |
| Depreciation Amortization | 7,650 | 5,107 | 2,486 | 9,297 | 6,930 |
| Accounts receivable | 116 | -412 | -8,612 | 6,407 | 7,279 |
| Other Working Capital | -15,697 | -9,310 | -6,590 | -9,897 | -14,546 |
| Other Operating Activity | 12,212 | 8,737 | 13,994 | -46,697 | -50,208 |
| Operating Cash Flow | $-73,239 | $-46,980 | $-23,017 | $-101,398 | $-78,992 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,568 | -1,769 | -1,069 | -8,858 | -6,397 |
| Sale Of Investment | N/A | N/A | N/A | 49,553 | 49,553 |
| Other Investing Activity | -55 | -55 | 0 | 209 | 209 |
| Investing Cash Flow | $-8,623 | $-1,824 | $-1,069 | $40,904 | $43,365 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,829 | -1,184 | -570 | -2,057 | -1,507 |
| Common Stock Issued | 102,934 | 102,663 | 101,979 | 5,225 | 4,892 |
| Financing Cash Flow | $101,105 | $101,479 | $101,409 | $3,168 | $3,385 |
| Exchange Rate Effect | -1,172 | 817 | 449 | -1,343 | -1,308 |
| Beginning Cash Position | 163,209 | 163,209 | 163,209 | 221,878 | 221,878 |
| End Cash Position | 181,280 | 216,701 | 240,981 | 163,209 | 188,328 |
| Net Cash Flow | $18,071 | $53,492 | $77,772 | $-58,669 | $-33,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,239 | -46,980 | -23,017 | -101,398 | -78,992 |
| Capital Expenditure | -10,800 | -1,769 | -1,069 | -8,905 | -6,444 |
| Free Cash Flow | -84,039 | -48,749 | -24,086 | -110,303 | -85,436 |